Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne W Hancock

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Immunological Reviews|November 18, 2003
Chemokine receptor-dependent alloresponsesWayne W Hancock
Handbook of Experimental Pharmacology|September 1, 2011
Rationale for HDAC inhibitor therapy in autoimmunity and transplantationWayne W Hancock
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 11, 2007
Regulating regulatory T cells to achieve transplant toleranceRan Tao, Wayne W Hancock
Plos One|May 30, 2008
Resistance of Foxp3+ regulatory T cells to Nur77-induced apoptosis promotes allograft survivalRan Tao, Wayne W Hancock
Plos One|November 20, 2009
Three distinct domains contribute to nuclear transport of murine Foxp3Wayne W Hancock, Engin Ozkaynak
Frontiers in Immunology|July 7, 2022
Nuclear Coregulatory Complexes in Tregs as Targets to Promote Anticancer Immune ResponsesLanette M Christensen, Wayne W Hancock
Immunology and Cell Biology|January 28, 2009
Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft toleranceLiqing Wang, Ran Tao, Wayne W Hancock
European Journal of Immunology|September 28, 2007
Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft toleranceLiqing Wang, Rongxiang Han, Wayne W Hancock
Cell Cycle (Georgetown, Tex.)|August 25, 2012
Combination of isoform-selective histone/protein deacetylase inhibitors improves Foxp3+ T-regulatory cell functionUlf H Beier, Liqing Wang, Wayne W Hancock
Biochimica Et Biophysica Acta. Reviews on Cancer|June 8, 2018
MEF2 and the tumorigenic process, hic sunt leonesEros Di Giorgio, Wayne W Hancock, Claudio Brancolini
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Immunological Reviews|November 18, 2003
Chemokine receptor-dependent alloresponsesWayne W Hancock
Handbook of Experimental Pharmacology|September 1, 2011
Rationale for HDAC inhibitor therapy in autoimmunity and transplantationWayne W Hancock
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 11, 2007
Regulating regulatory T cells to achieve transplant toleranceRan Tao, Wayne W Hancock
Plos One|May 30, 2008
Resistance of Foxp3+ regulatory T cells to Nur77-induced apoptosis promotes allograft survivalRan Tao, Wayne W Hancock
Plos One|November 20, 2009
Three distinct domains contribute to nuclear transport of murine Foxp3Wayne W Hancock, Engin Ozkaynak
Frontiers in Immunology|July 7, 2022
Nuclear Coregulatory Complexes in Tregs as Targets to Promote Anticancer Immune ResponsesLanette M Christensen, Wayne W Hancock
Immunology and Cell Biology|January 28, 2009
Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft toleranceLiqing Wang, Ran Tao, Wayne W Hancock
European Journal of Immunology|September 28, 2007
Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft toleranceLiqing Wang, Rongxiang Han, Wayne W Hancock
Cell Cycle (Georgetown, Tex.)|August 25, 2012
Combination of isoform-selective histone/protein deacetylase inhibitors improves Foxp3+ T-regulatory cell functionUlf H Beier, Liqing Wang, Wayne W Hancock
Biochimica Et Biophysica Acta. Reviews on Cancer|June 8, 2018
MEF2 and the tumorigenic process, hic sunt leonesEros Di Giorgio, Wayne W Hancock, Claudio Brancolini
Pageof 17